After a tumultuous year, experts call for stability while anticipating the first fruits of policies intended to expedite ...

One way Takeda lives out its values is by striving to ensure that patients are aware of and can access the company’s clinical ...

As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate ...

We are a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases through cell therapy. Cell therapy is a process of using a patient’s own cells to better ...

At Insmed, every moment and every patient counts — and so does every person who joins in. As a global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare ...